John Leonard Anderson
Affiliations: | 1971-1976 | Chemical Engineering | Cornell University, Ithaca, NY, United States |
| 1976-2004 | Chemical Engineering | Carnegie Mellon University, Pittsburgh, PA | |
| 2004-2007 | Chemical Engineering | Case Western Reserve University, Cleveland Heights, OH, United States | |
| 2007-2015 | Chemical Engineering | Illinois Institute of Technology, Chicago, IL, United States |
Area:
colloidal hydrodynamics and membrane transport phenomenaWebsite:
https://www.iit.edu/directory/people/john-andersonGoogle:
""John Leonard Anderson Chemical Engineering""Bio:
https://web.iit.edu/sites/web/files/departments/president/pdfs/JLA_CV_8-7-14.pdf
https://www.nae.edu/27559/Dr-John-L-Anderson
https://www.nae.edu/212011/JohnLAnderson
https://scholar.google.com/citations?user=VdmINPIAAAAJ&hl=en
Parents
Sign in to add mentor| John A. Quinn | grad student | 1971 | UIUC (Chemistry Tree) | |
| (The Characterization of Mass and Charge Transport: Development of a Model Membrane) | ||||
Children
Sign in to add trainee| Ruth E. Baltus | grad student | 1982 | Carnegie Mellon |
| Darrell Velegol | grad student | 1997 | Carnegie Mellon (Microtree) |
| Scott A. Guelcher | grad student | 1999 | Carnegie Mellon |
| Kristen L. Buehler | grad student | 2000 | Carnegie Mellon (Neurotree) |
| Junhyung Kim | grad student | 2004 | Carnegie Mellon (Physics Tree) |
| Jess Nauman | grad student | 2005 | Carnegie Mellon (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vydra J, Cosimo E, Lesný P, et al. (2023) A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma & Leukemia |
| Ferry GM, Agbuduwe C, Forrester M, et al. (2022) A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy. Frontiers in Immunology. 13: 863155 |
| Anderson J, Majzner RG, Sondel PM. (2022) Immunotherapy of Neuroblastoma: Facts and Hopes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Meier S, Cantilena S, Niklison Chirou MV, et al. (2021) Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation. Cell Death & Disease. 12: 785 |
| Paraboschi I, Privitera L, Kramer-Marek G, et al. (2021) Novel Treatments and Technologies Applied to the Cure of Neuroblastoma. Children (Basel, Switzerland). 8 |
| Hussein M, Alzoubaidi D, O'Donnell M, et al. (2021) Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes. Journal of Gastroenterology and Hepatology |
| Frosch J, Leontari I, Anderson J. (2021) Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment. Cancers. 13 |
| Paraboschi I, Turnock S, Kramer-Marek G, et al. (2021) Near-infrared photoimmunoTherapy (NIR-PIT) for the local control of solid cancers: challenges and potentials for human applications. Critical Reviews in Oncology/Hematology. 103325 |
| Straathof K, Flutter B, Wallace R, et al. (2020) Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma. Science Translational Medicine. 12 |
| Grabovska Y, Mackay A, O'Hare P, et al. (2020) Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity. Nature Communications. 11: 4324 |